Published in Am J Med on July 01, 2004
Epidemiology of Venous Thrombosis and Pulmonary Embolism (LITE) | NCT00005504
The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol (2008) 3.50
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms. Ann Emerg Med (2010) 2.19
Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol (2014) 2.08
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood (2009) 2.07
Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. Am J Obstet Gynecol (2012) 2.03
Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90
Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol (2007) 1.80
Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation (2014) 1.69
Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies. J Thromb Haemost (2012) 1.66
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation (2012) 1.59
Venous thromboembolism-related mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia. Ann Thorac Med (2011) 1.56
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. J Natl Cancer Inst (2010) 1.44
New insights into the mechanisms of venous thrombosis. J Clin Invest (2012) 1.32
Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. J Thromb Haemost (2009) 1.30
Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health (2009) 1.18
Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost (2012) 1.13
Activated partial thromboplastin time and risk of future venous thromboembolism. Am J Med (2008) 1.12
C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort. Thromb Haemost (2009) 1.11
Accuracy in diagnosing deep and pelvic vein thrombosis in primary care: an analysis of 395 cases seen by 58 primary care physicians. Dtsch Arztebl Int (2012) 1.10
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
Prospective study of sickle cell trait and venous thromboembolism incidence. J Thromb Haemost (2014) 1.08
Healthcare disparities in critical illness. Crit Care Med (2013) 1.08
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE). Blood (2008) 1.07
CT venography vs ultrasound in the diagnosis of thromboembolic disease in patients with clinical suspicion of pulmonary embolism. Emerg Radiol (2007) 1.04
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood (2008) 1.03
Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med (2013) 1.01
Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost (2008) 1.01
The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00
Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study. J Thromb Haemost (2009) 0.99
Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol (2010) 0.98
Haematology and neurology. J Neurol Neurosurg Psychiatry (2007) 0.96
Diet and incident venous thromboembolism: the Iowa Women's Health Study. Am Heart J (2009) 0.94
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood (2014) 0.94
Natural history of patients with congenital dysfibrinogenemia. Blood (2014) 0.92
Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study. Br J Haematol (2009) 0.91
Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? World J Cardiol (2015) 0.90
Recurrent arterial and venous thromboemboli as initial presentation of acute promyelocytic leukemia. J Clin Med Res (2014) 0.90
Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant (2010) 0.89
Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies. Thromb Haemost (2010) 0.88
Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res (2016) 0.88
Predicting the risk of venous thromboembolism recurrence. Am J Hematol (2012) 0.88
The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res (2007) 0.87
Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis. Nat Rev Rheumatol (2012) 0.86
National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010). Am J Cardiol (2015) 0.86
Psoriasis is associated with a greater risk of incident venous thromboembolism: the Iowa Women's Health Study. J Thromb Haemost (2012) 0.85
Serum albumin and risk of venous thromboembolism. Thromb Haemost (2010) 0.84
Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients. World J Surg (2011) 0.84
Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE). Thromb Haemost (2011) 0.84
Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses. J Med Life (2011) 0.84
Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology. Thromb Haemost (2010) 0.84
American Heart Association's Life's Simple 7 and incidence of venous thromboembolism. Am J Hematol (2015) 0.83
Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis. Thromb Res (2007) 0.83
Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Res (2015) 0.82
Traffic exposure and incident venous thromboembolism in the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost (2011) 0.82
Recurrent venous thromboembolism: what is the risk and how to prevent it. Scientifica (Cairo) (2012) 0.82
Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis. Asian J Transfus Sci (2012) 0.82
Sleep, death, and the heart. Am J Physiol Heart Circ Physiol (2015) 0.82
Current status of the Korean venous thromboembolism registry. Yonsei Med J (2011) 0.81
Invited commentary: Diet and risk of venous thromboembolism--a hard nut to crack. Am J Epidemiol (2011) 0.81
Public health surveillance of nonmalignant blood disorders. Am J Prev Med (2014) 0.81
Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost (2014) 0.81
Testing for thrombophilia: an evidence-based approach. Postgrad Med J (2006) 0.81
Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study. Vasc Med (2013) 0.80
Lifetime Risk of Venous Thromboembolism in Two Cohort Studies. Am J Med (2015) 0.80
Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Vasc Med (2014) 0.79
Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia. BMC Womens Health (2007) 0.79
Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults. Am J Hematol (2008) 0.79
Noise-optimized virtual monoenergetic images and iodine maps for the detection of venous thrombosis in second-generation dual-energy CT (DECT): an ex vivo phantom study. Eur Radiol (2014) 0.78
Deep Vein Thrombosis among Intensive Care Unit Patients; an Epidemiologic Study. Emerg (Tehran) (2017) 0.78
Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Br J Haematol (2010) 0.78
The Saudi clinical practice guideline for the diagnosis of the first deep venous thrombosis of the lower extremity. Ann Thorac Med (2015) 0.78
The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Tromsø study. Eur J Epidemiol (2014) 0.78
Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management. Thromb J (2012) 0.78
Lipoprotein(a) and venous thromboembolism. Am J Med (2008) 0.78
Transitions of care in anticoagulated patients. J Multidiscip Healthc (2013) 0.78
Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. Thromb Res (2016) 0.77
Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology. Thromb Res (2016) 0.77
Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study. J Thromb Haemost (2016) 0.77
Replication of findings on the association of genetic variation in 24 hemostasis genes and risk of incident venous thrombosis. J Thromb Haemost (2009) 0.77
White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study. PLoS One (2013) 0.77
Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis. Diabetes Res Clin Pract (2015) 0.77
Hereditary thrombophilia in Korean patients with idiopathic pulmonary embolism. Yonsei Med J (2012) 0.77
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis. Thromb J (2014) 0.77
Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans. J Thromb Haemost (2015) 0.77
The predictive factors of recurrent deep vein thrombosis. ARYA Atheroscler (2011) 0.77
Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thromb Res (2015) 0.77
Physical activity and risk of venous thromboembolism. The Tromso study. Haematologica (2010) 0.76
Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism. Vasc Health Risk Manag (2011) 0.76
Management of venous thromboembolism in patients with advanced gastrointestinal cancers: what is the role of novel oral anticoagulants? Thrombosis (2012) 0.76
Utilization of parenteral anticoagulants and warfarin: impact on the risk of venous thromboembolism recurrence in the outpatient setting. Am Health Drug Benefits (2014) 0.76
The role of thrombolytic therapy in pulmonary embolism. Blood (2015) 0.75
Is thromboprophylaxis effective in reducing the pulmonary thromboembolism? ARYA Atheroscler (2012) 0.75
Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies. Am J Hypertens (2015) 0.75
Limb necrosis in a lung cancer case presenting with widespread thrombosis. Case Rep Vasc Med (2012) 0.75
Dynamic affinity chromatography in the separation of sulfated lignins binding to thrombin. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.75
Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study. Haematologica (2012) 0.75
One decade "narcotic addicted patients with deep vein thrombosis" in st. Alzahra hospital of isfahan, iran. Addict Health (2015) 0.75
Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study. Ann Epidemiol (2014) 0.75
Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
A common allele on chromosome 9 associated with coronary heart disease. Science (2007) 20.37
Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75
Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06
Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol (2003) 8.64
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 5.98
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol (2010) 5.79
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2003) 5.43
Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol (2011) 5.30
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation (2009) 5.26
Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20
The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol (2008) 5.05
Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J (2009) 4.90
Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol (2008) 4.83
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care (2005) 4.38
Antibiotic use in relation to the risk of breast cancer. JAMA (2004) 4.28
Physical activity and stroke risk: a meta-analysis. Stroke (2003) 4.19
Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med (2006) 4.10
Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study. Arch Intern Med (2007) 4.05
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care (2005) 3.96
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation (2004) 3.96
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med (2006) 3.91
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Genome-wide association study of PR interval. Nat Genet (2010) 3.73
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA (2007) 3.50
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol (2003) 3.40
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med (2006) 3.33
Trends in prehospital delay time and use of emergency medical services for acute myocardial infarction: experience in 4 US communities from 1987-2000. Am Heart J (2005) 3.32
Genetic ancestry in lung-function predictions. N Engl J Med (2010) 3.30
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18
Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med (2002) 3.15
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14
Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet (2011) 3.07
Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care (2009) 3.06
Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med (2010) 3.05
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Genetic associations with valvular calcification and aortic stenosis. N Engl J Med (2013) 3.02
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med (2005) 3.00
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol (2004) 3.00
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92
Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet (2010) 2.91
Functional limitations in elderly female cancer survivors. J Natl Cancer Inst (2006) 2.89
Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2005) 2.82
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation (2010) 2.78
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2003) 2.76
Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med (2005) 2.67
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes (2012) 2.61
Prediction of critical illness during out-of-hospital emergency care. JAMA (2010) 2.60
Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000. Am J Epidemiol (2004) 2.59
Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet (2009) 2.58
Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation (2006) 2.57
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54
Left ventricular concentric remodeling is associated with decreased global and regional systolic function: the Multi-Ethnic Study of Atherosclerosis. Circulation (2005) 2.54
Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol (2007) 2.53
The World Trade Center disaster and the health of workers: five-year assessment of a unique medical screening program. Environ Health Perspect (2006) 2.52
Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med (2003) 2.49
Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int (2009) 2.48
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47
Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol (2004) 2.46
Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med (2006) 2.45
Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2002) 2.43